作者: Yu-Hsiang Chou , Szu-Yu Pan , Chian-Huei Yang , Shuei-Liong Lin
DOI: 10.1016/J.JFMA.2013.12.001
关键词:
摘要: Kidney disease is an escalating burden all over the world. In addition to preventing kidney injury, regenerating damaged renal tissue as important retard progression of chronic end stage disease. Although a delicate organ and has only limited regenerative capacity compared other organs, increasing understanding development reprogramming kindled prospects options for Here, we will review advances in regeneration including manipulation tubular cells, fibroblasts, endothelial macrophages Several types stem such bone marrow-derived adipocyte-derived mesenchymal embryonic induced pluripotent cells are also applied regeneration. Endogenous or lineage reprogrammed progenitor represent attractive possibility differentiation into multiple cell types. Angiogenesis can ameliorate hypoxia fibrosis. Based on these studies knowledge, hope innovate more reliable pharmacological biotechnical methods medicine.